Top Healthcare Stocks in Citigroup's Q3 Portfolio Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Novartis Ag (NYSE:NVS): On 06/30/2011, Citigroup reported ... |
